Plain-English translation of NCT06885736 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When people take semaglutide or tirzepatide for weight loss, they can lose both fat and muscle. This study is testing whether adding strength training exercises and eating more protein can help preserve your muscle mass and keep you physically strong during treatment with these medications. Researchers want to see if these simple changes make a real difference in how people feel and function.
Weight loss medications work well, but they can cause people to lose muscle along with fat—which can make you feel weaker and less able to do everyday activities. This study is trying to find out if exercise and protein can prevent that muscle loss, so you get healthier without losing strength.
You likely qualify if…
You likely don't qualify if…
You will start the weight loss medication at a low dose and gradually increase it over time. You'll be randomly assigned to one of four groups: medication alone, medication plus extra protein, medication plus strength training exercises, or medication plus both protein and exercises. If you're in an exercise group, you'll do strength training three times per week for 6 months, with the first few sessions supervised by a trainer and group check-ins every 4 weeks. Throughout the study, you'll have follow-up visits to measure your muscle mass, strength, weight, blood sugar control, and quality of life.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Kuwait